Table 2.
Showing the Effectiveness of the BEAT Study Regimen Among Patients Enrolled in the BEAT-India Study
| Outcome | FQ Resistant | FQ Sensitive, SLI Resistant | Overall |
|---|---|---|---|
| Total no. of patients | 158a | 7 | 165 |
| Modified intent-to-treat population | |||
| Withdrawal based on drug sensitivity profile/culture negativity | 10 | 2 | 12 |
| No. of patients | 148 | 5 | 153 |
| Favorable outcome | |||
| No. of patients | 134 | 5 | 139 |
| Percentage of patients (95% CI) | 91 (85–95) | 100 (47–100) | 91 (85–95) |
| Unfavorable outcome | 14b | 0 | 14b |
Abbreviations: CI, confidence interval; FQ, fluoroquinolone; SLI, second-line resistance.
Sixteen patients had both FQ and SLI resistance.
One withdrawal from treatment during week 10 due to pregnancy.